Kitatani Kazuyuki, Idkowiak-Baldys Jolanta, Hannun Yusuf A
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA.
J Biol Chem. 2007 Jul 13;282(28):20647-56. doi: 10.1074/jbc.M609162200. Epub 2007 May 15.
Sustained activation of protein kinase C (PKC) isoenzymes alpha and betaII leads to their translocation to a perinuclear region and to the formation of the pericentrion, a PKC-dependent subset of recycling endosomes. In MCF-7 human breast cancer cells, the action of the PKC activator 4beta-phorbol-12-myristate-13-acetate (PMA) evokes ceramide formation, which in turn prevents PKCalpha/betaII translocation to the pericentrion. In this study we investigated the mechanisms by which ceramide negatively regulates this translocation of PKCalpha/betaII. Upon PMA treatment, HEK-293 cells displayed dual phosphorylation of PKCalpha/betaII at carboxyl-terminal sites (Thr-638/641 and Ser-657/660), whereas in MCF-7 cells PKCalpha/betaII were phosphorylated at Ser-657/660 but not Thr-638/641. Inhibition of ceramide synthesis by fumonisin B1 overcame the defect in PKC phosphorylation and restored translocation of PKCalpha/betaII to the pericentrion. To determine the involvement of ceramide-activated protein phosphatases in PKC regulation, we employed small interference RNA to silence individual Ser/Thr protein phosphatases. Knockdown of isoforms alpha or beta of the catalytic subunits of protein phosphatase 1 not only increased phosphorylation of PKCalpha/betaII at Thr-638/641 but also restored PKCbetaII translocation to the pericentrion. Mutagenesis approaches in HEK-293 cells revealed that mutation of either Thr-641 or Ser-660 to Ala in PKCbetaII abolished sequestration of PKC, implying the indispensable roles of phosphorylation of PKCalpha/betaII at those sites for their translocation to the pericentrion. Reciprocally, a point mutation of Thr-641 to Glu, which mimics phosphorylation, in PKCbetaII overcame the inhibitory effects of ceramide on PKC translocation in PMA-stimulated MCF-7 cells. Therefore, the results demonstrate a novel role for carboxyl-terminal phosphorylation of PKCalpha/betaII in the translocation of PKC to the pericentrion, and they disclose specific regulation of PKC autophosphorylation by ceramide through the activation of specific isoforms of protein phosphatase 1.
蛋白激酶C(PKC)同工酶α和βII的持续激活会导致它们易位至核周区域,并形成中心粒周体,这是一种依赖PKC的循环内体亚群。在MCF-7人乳腺癌细胞中,PKC激活剂4β-佛波醇-12-肉豆蔻酸酯-13-乙酸酯(PMA)的作用会引发神经酰胺的形成,进而阻止PKCα/βII易位至中心粒周体。在本研究中,我们探究了神经酰胺负向调节PKCα/βII这种易位的机制。用PMA处理后,HEK-293细胞在PKCα/βII的羧基末端位点(苏氨酸-638/641和丝氨酸-657/660)出现双重磷酸化,而在MCF-7细胞中,PKCα/βII仅在丝氨酸-657/660位点发生磷酸化,而苏氨酸-638/641位点未发生磷酸化。伏马菌素B1抑制神经酰胺合成克服了PKC磷酸化缺陷,并恢复了PKCα/βII向中心粒周体的易位。为了确定神经酰胺激活的蛋白磷酸酶在PKC调节中的作用,我们采用小干扰RNA来沉默单个丝氨酸/苏氨酸蛋白磷酸酶。敲低蛋白磷酸酶1催化亚基的α或β同工型不仅增加了PKCα/βII在苏氨酸-638/641位点的磷酸化,还恢复了PKCβII向中心粒周体的易位。在HEK-293细胞中进行的诱变研究表明,PKCβII中苏氨酸-641或丝氨酸-660突变为丙氨酸会消除PKC的隔离,这意味着PKCα/βII在这些位点的磷酸化对于它们向中心粒周体的易位不可或缺。相反,PKCβII中苏氨酸-641突变为谷氨酸(模拟磷酸化)的点突变克服了神经酰胺对PMA刺激的MCF-7细胞中PKC易位的抑制作用。因此,这些结果证明了PKCα/βII羧基末端磷酸化在PKC向中心粒周体易位中的新作用,并且揭示了神经酰胺通过激活蛋白磷酸酶1的特定同工型对PKC自身磷酸化的特异性调节。